LAMBERTI, GIUSEPPE
LAMBERTI, GIUSEPPE
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective
2021 Spada F.; Campana D.; Lamberti G.; Laudicella R.; Dellamano R.; Dellamano L.; Leeuwenkamp O.; Baldari S.
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?
2022 Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; Ricci C.; Casadei R.; Fanti S.; Ambrosini V.
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions
2022 Cortellini A.; Barrichello A.P.C.; Alessi J.V.; Ricciuti B.; Vaz V.R.; Newsom-Davis T.; Evans J.S.; Lamberti G.; Pecci F.; Viola P.; D'Alessio A.; Fulgenzi C.A.M.; Awad M.M.; Pinato D.J.
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
2022 Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.; Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G.
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances
2021 Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G.
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma
2022 La Salvia A.; Carletti R.; Verrico M.; Feola T.; Puliani G.; Bassi M.; Sesti F.; Pernazza A.; Mazzilli R.; Lamberti G.; Siciliani A.; Mancini M.; Manai C.; Venuta F.; Ibrahim M.; Tomao S.; D'Amati G.; Di Gioia C.; Giannetta E.; Cappuzzo F.; Faggiano A.
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
2020 Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F.
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
2021 Cortellini A.; Ricciuti B.; Facchinetti F.; Alessi J.V.M.; Venkatraman D.; Dall'Olio F.G.; Cravero P.; Vaz V.R.; Ottaviani D.; Majem M.; Piedra A.; Sullivan I.; Lee K.A.; Lamberti G.; Hussain N.; Clark J.; Bolina A.; Barba A.; Benitez J.C.; Gorria T.; Mezquita L.; Hoton D.; Aboubakar Nana F.; Besse B.; Awad M.M.; Pinato D.J.
Antibody–drug conjugates for lung cancer in the era of personalized oncology
2021 Ricciuti B.; Lamberti G.; Andrini E.; Genova C.; De Giglio A.; Bianconi V.; Sahebkar A.; Chiari R.; Pirro M.
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis
2023 Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Valentina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study
2022 Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricco G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D.
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC
2020 Ricciuti B.; Naqash A.R.; Naidoo J.; Sehgal K.; Miller A.; Kehl K.; Venkatraman D.; Sands J.; Lamberti G.; Recondo G.; Zhang J.; Macherla S.; Baig S.; Walker P.; Rangachari D.; Gainor J.F.; Costa D.B.; Rizvi N.; Sholl L.M.; Nishino M.; Henick B.; Farago A.F.; Awad M.M.
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers with Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
2022 Ricciuti B.; Wang X.; Alessi J.V.; Rizvi H.; Mahadevan N.R.; Li Y.Y.; Polio A.; Lindsay J.; Umeton R.; Sinha R.; Vokes N.I.; Recondo G.; Lamberti G.; Lawrence M.; Vaz V.R.; Leonardi G.C.; Plodkowski A.J.; Gupta H.; Cherniack A.D.; Tolstorukov M.Y.; Sharma B.; Felt K.D.; Gainor J.F.; Ravi A.; Getz G.; Schalper K.A.; Henick B.; Forde P.; Anagnostou V.; Janne P.A.; Van Allen E.M.; Nishino M.; Sholl L.M.; Christiani D.C.; Lin X.; Rodig S.J.; Hellmann M.D.; Awad M.M.
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
2022 Pusceddu, Sara; Prinzi, Natalie; Tafuto, Salvatore; Ibrahim, Toni; Filice, Angelina; Brizzi, Maria Pia; Panzuto, Francesco; Baldari, Sergio; Grana, Chiara M.; Campana, Davide; Davì, Maria Vittoria; Giuffrida, Dario; Zatelli, Maria Chiara; Partelli, Stefano; Razzore, Paola; Marconcini, Riccardo; Massironi, Sara; Gelsomino, Fabio; Faggiano, Antongiulio; Giannetta, Elisa; Bajetta, Emilio; Grimaldi, Franco; Cives, Mauro; Cirillo, Fernando; Perfetti, Vittorio; Corti, Francesca; Ricci, Claudio; Giacomelli, Luca; Porcu, Luca; Di Maio, Massimo; Seregni, Ettore; Maccauro, Marco; Lastoria, Secondo; Bongiovanni, Alberto; Versari, Annibale; Persano, Irene; Rinzivillo, Maria; Pignata, Salvatore Antonio; Rocca, Paola Anna; Lamberti, Giuseppe; Cingarlini, Sara; Puliafito, Ivana; Ambrosio, Maria Rosaria; Zanata, Isabella; Bracigliano, Alessandra; Severi, Stefano; Spada, Francesca; Andreasi, Valentina; Modica, Roberta; Scalorbi, Federica; Milione, Massimo; Sabella, Giovanna; Coppa, Jorgelina; Casadei, Riccardo; Di Bartolomeo, Maria; Falconi, Massimo; de Braud, Filippo
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)
2020 Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Mandruzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A.
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
2020 Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A.
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
2020 Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lamberti G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D.
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature
2023 Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; Lamberti G.
Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option
2019 Ricciuti B.; Lamberti G.; Roila F.; Metro G.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective | Spada F.; Campana D.; Lamberti G.; Laudicella R.; Dellamano R.; Dellamano L.; Leeuwenkamp O.; Bal...dari S. | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | Spada2021_Article_[177Lu]Lu-DOTA-TATEVersusStand.pdf; 259_2021_5656_MOESM1_ESM.docx |
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? | Tabacchi E.; Fortunati E.; Argalia G.; Zanoni L.; Calabro D.; Telo S.; Campana D.; Lamberti G.; R...icci C.; Casadei R.; Fanti S.; Ambrosini V. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03541.pdf |
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions | Cortellini A.; Barrichello A.P.C.; Alessi J.V.; Ricciuti B.; Vaz V.R.; Newsom-Davis T.; Evans J.S....; Lamberti G.; Pecci F.; Viola P.; D'Alessio A.; Fulgenzi C.A.M.; Awad M.M.; Pinato D.J. | 2022-01-01 | ANNALS OF ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | 2022-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease | Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. | 2022-01-01 | DRUGS IN CONTEXT | - | 1.01 Articolo in rivista | - |
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances | Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G. | 2021-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | pharmaceuticals-14-00316.pdf |
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma | La Salvia A.; Carletti R.; Verrico M.; Feola T.; Puliani G.; Bassi M.; Sesti F.; Pernazza A.; Maz...zilli R.; Lamberti G.; Siciliani A.; Mancini M.; Manai C.; Venuta F.; Ibrahim M.; Tomao S.; D'Amati G.; Di Gioia C.; Giannetta E.; Cappuzzo F.; Faggiano A. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-05958-v2.pdf |
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience | Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F. | 2020-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy | Cortellini A.; Ricciuti B.; Facchinetti F.; Alessi J.V.M.; Venkatraman D.; Dall'Olio F.G.; Craver...o P.; Vaz V.R.; Ottaviani D.; Majem M.; Piedra A.; Sullivan I.; Lee K.A.; Lamberti G.; Hussain N.; Clark J.; Bolina A.; Barba A.; Benitez J.C.; Gorria T.; Mezquita L.; Hoton D.; Aboubakar Nana F.; Besse B.; Awad M.M.; Pinato D.J. | 2021-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
Antibody–drug conjugates for lung cancer in the era of personalized oncology | Ricciuti B.; Lamberti G.; Andrini E.; Genova C.; De Giglio A.; Bianconi V.; Sahebkar A.; Chiari R....; Pirro M. | 2021-01-01 | SEMINARS IN CANCER BIOLOGY | - | 1.01 Articolo in rivista | - |
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis | Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Vale...ntina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo | 2023-01-01 | LANGENBECK'S ARCHIVES OF SURGERY | - | 1.01 Articolo in rivista | GCC_cht_SEER.pdf |
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study | Ricci A.D.; Pusceddu S.; Panzuto F.; Gelsomino F.; Massironi S.; De Angelis C.G.; Modica R.; Ricc...o G.; Torchio M.; Rinzivillo M.; Prinzi N.; Rizzi F.; Lamberti G.; Campana D. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-00713-v2.pdf |
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC | Ricciuti B.; Naqash A.R.; Naidoo J.; Sehgal K.; Miller A.; Kehl K.; Venkatraman D.; Sands J.; Lam...berti G.; Recondo G.; Zhang J.; Macherla S.; Baig S.; Walker P.; Rangachari D.; Gainor J.F.; Costa D.B.; Rizvi N.; Sholl L.M.; Nishino M.; Henick B.; Farago A.F.; Awad M.M. | 2020-01-01 | JTO CLINICAL AND RESEARCH REPORTS | - | 1.01 Articolo in rivista | 1-s2.0-S2666364320300977-main.pdf; ScienceDirect_files_21Apr2023_09-58-05.374.zip |
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers with Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels | Ricciuti B.; Wang X.; Alessi J.V.; Rizvi H.; Mahadevan N.R.; Li Y.Y.; Polio A.; Lindsay J.; Umeto...n R.; Sinha R.; Vokes N.I.; Recondo G.; Lamberti G.; Lawrence M.; Vaz V.R.; Leonardi G.C.; Plodkowski A.J.; Gupta H.; Cherniack A.D.; Tolstorukov M.Y.; Sharma B.; Felt K.D.; Gainor J.F.; Ravi A.; Getz G.; Schalper K.A.; Henick B.; Forde P.; Anagnostou V.; Janne P.A.; Van Allen E.M.; Nishino M.; Sholl L.M.; Christiani D.C.; Lin X.; Rodig S.J.; Hellmann M.D.; Awad M.M. | 2022-01-01 | JAMA ONCOLOGY | - | 1.01 Articolo in rivista | jamaoncology_ricciuti_2022_oi_220022_1671559773.22536(1).pdf; jamaoncol-e221981-s001.pdf |
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors | Pusceddu, Sara; Prinzi, Natalie; Tafuto, Salvatore; Ibrahim, Toni; Filice, Angelina; Brizzi, Mari...a Pia; Panzuto, Francesco; Baldari, Sergio; Grana, Chiara M.; Campana, Davide; Davì, Maria Vittoria; Giuffrida, Dario; Zatelli, Maria Chiara; Partelli, Stefano; Razzore, Paola; Marconcini, Riccardo; Massironi, Sara; Gelsomino, Fabio; Faggiano, Antongiulio; Giannetta, Elisa; Bajetta, Emilio; Grimaldi, Franco; Cives, Mauro; Cirillo, Fernando; Perfetti, Vittorio; Corti, Francesca; Ricci, Claudio; Giacomelli, Luca; Porcu, Luca; Di Maio, Massimo; Seregni, Ettore; Maccauro, Marco; Lastoria, Secondo; Bongiovanni, Alberto; Versari, Annibale; Persano, Irene; Rinzivillo, Maria; Pignata, Salvatore Antonio; Rocca, Paola Anna; Lamberti, Giuseppe; Cingarlini, Sara; Puliafito, Ivana; Ambrosio, Maria Rosaria; Zanata, Isabella; Bracigliano, Alessandra; Severi, Stefano; Spada, Francesca; Andreasi, Valentina; Modica, Roberta; Scalorbi, Federica; Milione, Massimo; Sabella, Giovanna; Coppa, Jorgelina; Casadei, Riccardo; Di Bartolomeo, Maria; Falconi, Massimo; de Braud, Filippo | 2022-01-01 | JAMA NETWORK OPEN | - | 1.01 Articolo in rivista | pusceddu_2022_oi_220024_1645038635.48021.pdf |
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) | Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Man...druzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A. | 2020-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | Gelsomino_CHANCE_TAMO'20.pdf |
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma | Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. | 2020-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study | Brighi N.; Panzuto F.; Modica R.; Gelsomino F.; Albertelli M.; Pusceddu S.; Massironi S.; Lambert...i G.; Rinzivillo M.; Faggiano A.; Spallanzani A.; Ferone D.; Prinzi N.; Rossi R.E.; Annibale B.; Colao A.M.; Campana D. | 2020-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature | Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; ...Lamberti G. | 2023-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option | Ricciuti B.; Lamberti G.; Roila F.; Metro G. | 2019-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | - |